Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.540
+0.170 (3.89%)
Mar 13, 2026, 10:27 AM EDT - Market open

Nuvation Bio Revenue

In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth. Nuvation Bio had revenue of $41.87M in the quarter ending December 31, 2025, with 633.06% growth.

Revenue (ttm)
$62.90M
Revenue Growth
+698.96%
P/S Ratio
24.58
Revenue / Employee
$216,158
Employees
291
Market Cap
1.56B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202562.90M55.03M698.96%
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Harmony Biosciences Holdings868.45M
Immunocore Holdings400.02M
Nurix Therapeutics83.98M
Vir Biotechnology68.56M
Intellia Therapeutics67.67M
Nanobiotix11.93M
Oculis Holding AG1.51M
Revenue Rankings

NUVB News

More News